Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REAL-LATE
NCT00484926Phase 4Completed
- Start
- Mar 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clopidogrel in coronary artery disease (CAD) (2 arms). Primary endpoint: Composite of cardiac death or myocardial infarction at 1 year. Started Mar 2007; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00484926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484926.